Literature DB >> 3359059

[Magnetic resonance imaging for bone marrow metastases of neuroblastoma].

D Couanet1, A Geoffray.   

Abstract

From March 1985 to February 1987, 41 patients (pts) presenting with a neuroblastoma underwent 52 MRI to detect bone marrow metastases. Mean age was 4 years (R: 6 m, 13 y). Acquisitions were done with a 1.5 t unit. Images were obtained in coronal (legs and pelvis) and sagittal (dorso-lumbar spine) sections. Nine out of 52 examinations were excluded because of artifacts or technical failure. In 13 cases, MRI was performed for initial staging, in 30 during follow-up. Out of 24 anatomically proven medullary involvement (18 pts), MRI showed focal abnormal signals in 23 (17 pts): foci of hypersignal in T2 weighted images, compared to the normal value of bone marrow and fat tissue, were more often detected in lower limbs than dorso-lumbar vertebral body or iliac bone. In our series, the sensitivity of MRI to detect BM metastases is 84% and the specificity is 88%. In comparison to the medullograms and bone marrow biopsy, MRI explores distinct sites, especially lower limbs which are often involved.

Entities:  

Mesh:

Year:  1988        PMID: 3359059

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  3 in total

1.  Which MRI sequence of the spine best reveals bone-marrow metastases of neuroblastoma?

Authors:  James S Meyer; Marilyn J Siegel; Saleem O Farooqui; Diego Jaramillo; Barry D Fletcher; Fredric A Hoffer
Journal:  Pediatr Radiol       Date:  2005-05-10

Review 2.  Where next with therapy in advanced neuroblastoma?

Authors:  C R Pinkerton
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

3.  Bone marrow metastases in small cell lung cancer: detection with magnetic resonance imaging and monoclonal antibodies.

Authors:  V Trillet; D Revel; V Combaret; M Favrot; R Loire; A Tabib; J Pages; P Jacquemet; A Bonmartin; J F Mornex
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.